Panagiotis Nikolaos Lalagkas (Panagiotis-Nikolaos Lalagkas)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

End Stage Renal Disease

Endothelial Cells

Top Venues

Bioinformatics advances

Expert opinion on drug metabolism & toxicology

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Mamoon Habib, Panagiotis Nikolaos Lalagkas, Rachel D Melamed
Mapping drug biology to disease genetics to discover drug impacts on the human phenome. Bioinformatics advances 4 (1) (2024)
Mamoon Habib, Panagiotis Nikolaos Lalagkas, Rachel D Melamed
Mapping drug biology to disease genetics to discover drug impacts on the human phenome. Bioinformatics advances 4 (1) (2024)
Panagiotis Nikolaos Lalagkas, Jorge Iliou, Raul Rigo, Marta Miarons, Beatriz Fernández-Alarcon, Oriol Bestard, Josep M Cruzado, Edoardo Melilli, Joan Torras, Josep M Grinyó, Nuria Lloberas, Helena Colom
Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population Approach. Clinical pharmacokinetics (2023)
Panagiotis Nikolaos Lalagkas, Georgios Poulentzas, Christos A Kontogiorgis, Antonios Douros
Potential drug-drug interaction between sodium-glucose co-transporter 2 inhibitors and statins: pharmacological and clinical evidence. Expert opinion on drug metabolism & toxicology 17 (6) (2021)